FILTER RESULTS
FILTER RESULTS
close.svg
Search Result for “Bipolar”

Showing 1 - 5 of 5

BUSINESS

Wars and Geopolitical Tensions Drive Global Oil Prices Higher 

Published on 19/09/2025

» Global crude oil prices have edged higher in recent months as prolonged wars and geopolitical tensions continue to disrupt energy supplies. Between July 1 and September 15, 2025, ICE Brent crude rose by US$1.51 per barrel from the previous quarter, averaging US$68.16 per barrel. The increase was driven mainly by the escalating war between Russia and Ukraine. Although US President Donald Trump and Russian President Vladimir Putin met in Alaska on August 15 to discuss a peace deal and ceasefire, the summit ended without agreement, and both sides continued retaliatory strikes. 

BUSINESS

CP boss touts 'Switzerland of Asean'

Business, KOMSAN TORTERMVASANA and KANANA KATHARANGSIPORN, Published on 21/11/2024

» Thailand could act as the "Switzerland of Asean" to attract global investment, especially from tech behemoths, in the bipolar political environment based on the country's neutral stance, says Suphachai Chearavanont, chief executive of conglomerate Charoen Pokphand (CP) Group.

BUSINESS

Asean-US balancing act

Asia focus, Ismira Lutfia Tisnadibrata and Nareerat Wiriyapong, Published on 25/04/2022

» The commitment of the United States to Southeast Asia since the end of the Vietnam War has been subject to a series of ebbs, flows and imbalances. History shows that it tends to wane whenever Washington is distracted by other global developments.

BUSINESS

Psychedelic drug firm gets rare endorsement from Big Pharma

Bloomberg News, Published on 05/01/2022

» The US arm of a prominent Japanese drugmaker has invested in a psychedelic drug discovery company in a rare endorsement by big pharma of the new and mostly illegal field of drugs.

BUSINESS

French state, Sanofi face ruling in birth defects case

AFP, Published on 01/07/2020

» PARIS - A French court is scheduled to rule Wednesday on the responsibility of the French state in birth defects linked to an anti-epilepsy drug produced by pharmaceutical giant Sanofi.